Dua perusahaan ternama di Indonesia, PT Glaxo Wellcome Indonesia atau GSK Indonesia dan PT Prodia Widyahusada Tbk (Prodia) menggelar penandatanganan Nota Kesepahaman (MoU) sebagai wujud komitmen ...

The health sector is experiencing a mix of challenges and breakthroughs. GE HealthCare is facing revenue setbacks due to China's anti-corruption drive. In contrast, Teva Pharma raises its forecasts on ...

The Health Ministry is pursuing strategic collaboration with public and private entities to ensure all adult citizens can gain access to information on ...

GSK Plc and Flagship Pioneering Inc. entered a partnership to develop as many as 10 new drugs in a deal that could pay more than $7 billion to firms supported by the venture capital biotech ...

Flagship Pioneering has signed yet another strategic-level deal with a big pharma group, with GSK the latest to tap into its network of biotech companies in an alliance that could be worth more ...

GSK is paying 400 million euros ($430 million) upfront for full rights to CureVac’s vaccines against influenza and COVID-19. The mRNA specialist shared news of the deal alongside a restructuring ...

GSK will assume full control of developing and manufacturing the candidate vaccines and will have worldwide rights to commercialise them. GSK and the biopharmaceutical firm Curevac have agreed to ...

GSK plc stock (NYSE: GSK) trades at $38 per share, about 20% below its peak level of over $47 seen in April 2022. In contrast, its peer Bristol Myers Squibb stock (NYSE: BMY) saw a 48% decline ...

As part of its action, the agency imposed a 15-day sales suspension from Aug. 1 to 15 on Duacgel 5%, according to KBR. GSK was fined 52.2 million won ($37,680) on Seretide 100 Discus, Seretide 250 ...